DAPT-话题@MedSci - 梅斯（MedSci）

#DAPT#

38篇内容 | 2224人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1374347, encodeId=6d9413e434719, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=JACC：双重抗血小板治疗评分（DAPT）遭质疑, objectType=article, longId=147567, objectId=977214e567be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=977214e567be, replyNumber=0, likeNumber=88, createdTime=2018-08-30, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=977214e567be, moduleTitle=JACC：双重抗血小板治疗评分（DAPT）遭质疑, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=977214e567be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374346, encodeId=e40913e4346ff, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, objectType=article, longId=147077, objectId=d1c714e077dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c714e077dc, replyNumber=0, likeNumber=99, createdTime=2018-08-22, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c714e077dc, moduleTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d1c714e077dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374345, encodeId=074f13e4345db, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷, objectType=article, longId=132571, objectId=4a911325e123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a911325e123, replyNumber=0, likeNumber=85, createdTime=2018-03-17, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a911325e123, moduleTitle=ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a911325e123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374344, encodeId=26f413e4344d9, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Eur Heart J：支架类型与DAPT持续时间对不良心血管事件有无影响？, objectType=article, longId=124743, objectId=7357124e437f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7357124e437f, replyNumber=0, likeNumber=79, createdTime=2017-12-28, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7357124e437f, moduleTitle=Eur Heart J：支架类型与DAPT持续时间对不良心血管事件有无影响？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7357124e437f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374343, encodeId=1a8813e43430e, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=J Am Coll Cardiol：复杂靶病变患者行PCI术后延长DAPT疗程能否带来获益？, objectType=article, longId=124729, objectId=387f124e2959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=387f124e2959, replyNumber=0, likeNumber=72, createdTime=2017-12-28, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=387f124e2959, moduleTitle=J Am Coll Cardiol：复杂靶病变患者行PCI术后延长DAPT疗程能否带来获益？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=387f124e2959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374342, encodeId=417913e4342f2, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=TCT2017 | DAPT STEMI研究：置入DES的STEMI患者，6个月DAPT不劣于12个月DAPT, objectType=article, longId=118816, objectId=50281188167a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50281188167a, replyNumber=0, likeNumber=70, createdTime=2017-11-06, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50281188167a, moduleTitle=TCT2017 | DAPT STEMI研究：置入DES的STEMI患者，6个月DAPT不劣于12个月DAPT, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=50281188167a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374341, encodeId=c0d913e4341b4, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Ann Intern Med：多学科讨论：DAPT评分确定PCI后DAPT治疗时间可行吗？, objectType=article, longId=107725, objectId=70a310e72596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70a310e72596, replyNumber=0, likeNumber=49, createdTime=2017-08-06, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70a310e72596, moduleTitle=Ann Intern Med：多学科讨论：DAPT评分确定PCI后DAPT治疗时间可行吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=70a310e72596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374340, encodeId=ed4513e4340d7, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Eur Heart J：DES后临床表现不同其更佳DAPT持续时间也不同, objectType=article, longId=98437, objectId=13e79843e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13e79843e98, replyNumber=0, likeNumber=56, createdTime=2017-05-12, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13e79843e98, moduleTitle=Eur Heart J：DES后临床表现不同其更佳DAPT持续时间也不同, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13e79843e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374339, encodeId=a34213e433979, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=JACC：冠脉支架植入后DAPT疗程不同死亡率有何差异？, objectType=article, longId=97925, objectId=f69e9e92505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f69e9e92505, replyNumber=0, likeNumber=76, createdTime=2017-05-06, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f69e9e92505, moduleTitle=JACC：冠脉支架植入后DAPT疗程不同死亡率有何差异？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f69e9e92505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374338, encodeId=51cf13e433869, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=双联抗血小板药物时限争议仍未终结---DAPT研究解读, objectType=article, longId=86437, objectId=f7ec8643ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7ec8643ea5, replyNumber=0, likeNumber=73, createdTime=2017-01-04, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7ec8643ea5, moduleTitle=双联抗血小板药物时限争议仍未终结---DAPT研究解读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f7ec8643ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374337, encodeId=26e513e4337b8, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=ESC 2016：短期 DAPT 效果不亚于长期, objectType=article, longId=76313, objectId=0084e63139d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0084e63139d, replyNumber=0, likeNumber=61, createdTime=2016-09-01, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0084e63139d, moduleTitle=ESC 2016：短期 DAPT 效果不亚于长期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0084e63139d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374336, encodeId=2e8e13e43360f, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=JACC：不管有无心肌梗死病史，DAPT得分均可预测后期风险, objectType=article, longId=69409, objectId=e239694097a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e239694097a, replyNumber=0, likeNumber=82, createdTime=2016-05-30, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e239694097a, moduleTitle=JACC：不管有无心肌梗死病史，DAPT得分均可预测后期风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e239694097a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374335, encodeId=67a913e433541, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=JACC：DES置入后短期和长期DAPT不良心脏事件及出血分析, objectType=article, longId=49076, objectId=a076490e62b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a076490e62b, replyNumber=0, likeNumber=61, createdTime=2015-04-09, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a076490e62b, moduleTitle=JACC：DES置入后短期和长期DAPT不良心脏事件及出血分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a076490e62b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374334, encodeId=cb0613e433427, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=JACC：DES置入后DAPT患者临床出血率及支架血栓率分析, objectType=article, longId=49053, objectId=3a184905373, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a184905373, replyNumber=0, likeNumber=93, createdTime=2015-04-09, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a184905373, moduleTitle=JACC：DES置入后DAPT患者临床出血率及支架血栓率分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3a184905373)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374333, encodeId=464413e433339, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Lancet：DAPT个体化治疗死亡风险分析, objectType=article, longId=49052, objectId=67784905293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67784905293, replyNumber=0, likeNumber=61, createdTime=2015-04-09, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67784905293, moduleTitle=Lancet：DAPT个体化治疗死亡风险分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67784905293)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374332, encodeId=48f413e4332a3, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Circ CQO：质子泵抑制剂与DAPT，究竟能否共生？, objectType=article, longId=46390, objectId=5b8a46390a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b8a46390a5, replyNumber=0, likeNumber=84, createdTime=2015-01-31, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b8a46390a5, moduleTitle=Circ CQO：质子泵抑制剂与DAPT，究竟能否共生？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5b8a46390a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374331, encodeId=088613e433126, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, objectType=article, longId=45399, objectId=22784539980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22784539980, replyNumber=0, likeNumber=63, createdTime=2015-01-15, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22784539980, moduleTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=22784539980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374330, encodeId=551313e4330cf, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), objectType=article, longId=42882, objectId=28904288280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28904288280, replyNumber=0, likeNumber=76, createdTime=2014-11-21, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28904288280, moduleTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28904288280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, objectTitle=Eur Heart J：R-ZES置入后早期中断DAPT与不良转归高风险相关, objectType=article, longId=30880, objectId=29303088068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29303088068, replyNumber=0, likeNumber=86, createdTime=2014-02-21, rootId=0, userName=mnda, userId=6a8d381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29303088068, moduleTitle=Eur Heart J：R-ZES置入后早期中断DAPT与不良转归高风险相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29303088068)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DAPT

2020-05-29

mnda (审核中...)

前往app查看评论内容

#DAPT#

JACC：双重抗血小板治疗评分（DAPT）遭质疑

2018-08-30

mnda (审核中...)

前往app查看评论内容

#DAPT#

J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较

2018-08-22

mnda (审核中...)

前往app查看评论内容

#DAPT#

ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷

2018-03-17

mnda (审核中...)

前往app查看评论内容

#DAPT#

Eur Heart J：支架类型与DAPT持续时间对不良心血管事件有无影响？

2017-12-28

mnda (审核中...)

前往app查看评论内容

#DAPT#

J Am Coll Cardiol：复杂靶病变患者行PCI术后延长DAPT疗程能否带来获益？

2017-12-28

mnda (审核中...)

前往app查看评论内容

#DAPT#

TCT2017 | DAPT STEMI研究：置入DES的STEMI患者，6个月DAPT不劣于12个月DAPT

2017-11-06

mnda (审核中...)

前往app查看评论内容

#DAPT#

Ann Intern Med：多学科讨论：DAPT评分确定PCI后DAPT治疗时间可行吗？

2017-08-06

mnda (审核中...)

前往app查看评论内容

#DAPT#

Eur Heart J：DES后临床表现不同其更佳DAPT持续时间也不同

2017-05-12

mnda (审核中...)

前往app查看评论内容

#DAPT#

JACC：冠脉支架植入后DAPT疗程不同死亡率有何差异？

2017-05-06

mnda (审核中...)

前往app查看评论内容

#DAPT#

双联抗血小板药物时限争议仍未终结---DAPT研究解读

2017-01-04

mnda (审核中...)

前往app查看评论内容

#DAPT#

ESC 2016：短期 DAPT 效果不亚于长期

2016-09-01

mnda (审核中...)

前往app查看评论内容

#DAPT#

JACC：不管有无心肌梗死病史，DAPT得分均可预测后期风险

2016-05-30

mnda (审核中...)

前往app查看评论内容

#DAPT#

JACC：DES置入后短期和长期DAPT不良心脏事件及出血分析

2015-04-09

mnda (审核中...)

前往app查看评论内容

#DAPT#

JACC：DES置入后DAPT患者临床出血率及支架血栓率分析

2015-04-09

mnda (审核中...)

前往app查看评论内容

#DAPT#

Lancet：DAPT个体化治疗死亡风险分析

2015-04-09

mnda (审核中...)

前往app查看评论内容

#DAPT#

Circ CQO：质子泵抑制剂与DAPT，究竟能否共生？

2015-01-31

mnda (审核中...)

前往app查看评论内容

#DAPT#

免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头

2015-01-15

mnda (审核中...)

前往app查看评论内容

#DAPT#

NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究)

2014-11-21

mnda (审核中...)

前往app查看评论内容

#DAPT#

Eur Heart J：R-ZES置入后早期中断DAPT与不良转归高风险相关

2014-02-21

科室
- - 订阅+
  - 更多科室
工具
服务